Related Experiment Video
Updated: Oct 16, 2025

08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
618
Learning Multi-Scale Heterogeneous Representations and Global Topology for Drug-Target Interaction Prediction
IEEE Journal of Biomedical and Health Informatics
|October 21, 2021
Summary
This study introduces a novel model for predicting drug-target interactions (DTIs) by integrating diverse data sources. The approach enhances drug discovery and repositioning by accurately identifying potential drug targets.
Area of Science:
- Computational Biology
- Bioinformatics
- Drug Discovery
Background:
- Accurate identification of drug-target interactions (DTIs) is crucial for drug discovery and repositioning.
- Integrating heterogeneous multi-source data for DTIs presents significant challenges due to complex inter-connections and intra-similarities.
Purpose of the Study:
- To develop a robust drug-target interaction prediction model.
- To effectively integrate multi-scale attributes and global topology from heterogeneous data sources.
Main Methods:
- Construction of a drug-protein-disease heterogeneous network (RPD-Net).
- Implementation of a multi-scale pairwise deep representation learning module with novel embedding and dilation convolutions.
- Application of a global topology learning module using non-negative matrix factorization (NMF) and relational-level attention.
Main Results:
- The proposed model demonstrates superior performance compared to existing state-of-the-art methods on public datasets.
- Experimental results validate the effectiveness of the multi-scale representation and global topology learning modules.
- High top k recall rates and successful case studies highlight the method's potential in identifying drug target candidates.
Conclusions:
- The developed RPD-Net model offers an effective approach for DTI prediction by deep integration of multi-source data.
- The method shows significant promise for advancing drug discovery and drug repositioning efforts.
- The model's ability to identify potential target candidates underscores its practical utility in pharmaceutical research.
Related Concept Videos
Protein-protein Interfaces
14.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.0K
Protein Networks
4.2K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Drug Discovery: Overview
9.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
148
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
148
Conserved Binding Sites
4.7K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.7K
Structure-Activity Relationships and Drug Design
1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K

